Tumor necrosis factor (TNF) blockers may help patients with rheumatoid arthritis (RA) maintain or increase their hours at work, investigators in Stockholm report in a new study. Reuters Health Information
In a small study of rheumatoid arthritis patients, treatment with the anti-tumor necrosis factor (anti-TNF) agent infliximab appeared to increase the antioxidative capacity of HDL cholesterol. Reuters Health Information
Pre-clinical and clinical studies have demonstrated that cannabis-based drugs have therapeutic potential in inflammatory diseases, including rheumatoid arthritis and multiple sclerosis. Arthritis Research & Therapy
Jonathan Kay, MD, summarizes the latest updates with tumor necrosis factor inhibitor for the treatment of RA, as illustrated by data from EULAR 2008. Medscape Rheumatology